T1D

NEW YORK, Nov. 6, 2025 /PRNewswire/ — Results of the Bayer-led Phase 3 FINE-ONE clinical trial, presented at the American Society of Nephrology Kidney Week in Houston, demonstrate that finerenone significantly …

Dealing with Diabetes Burnout https://amzn.to/3th5QF7 Ever wondered what it’s actually like to live with type 1 diabetes (T1D)?

More than 3,000 people took part in the annual Breakthrough T1D Walk at Coastal Credit Union Music Park at Walnut Creek on Sunday. The annual and national movement helps raise …

Throughout November, “See T1D”, creative will appear on billboards and digital displays across 22 major cities including New York, Washington D.C, Boston and San Francisco. A marquee element of the campaign …

The blood sugar guessing game is on! Drop your guess + actual number in the comments. Let’s see who can get the closest.

New  fundraising campaign will catalyze larger, higher-conviction investments to bolster promising T1D programs, leveraging the Fund’s strong track-record and management team Led by a $12 million donation from the Bukhman …

Our Digital Marketing Manager has had diabetes for 13+ years. How long has it been since your diagnosis? Tell us in the …

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved teprizumab (Tzield, Aventis Pharma Limited) as the UK's first immunotherapy for type 1 diabetes (T1D). The drug is approved for …

In this week’s issue of The Savvy Diabetic:  FDA Approves Kristy – Biosimilar to Novolog Dexcom Responds to Sensor Failures & More ‘Ozempic Teeth’ GLP-1 Side Effect Innovations in Preventing/Treating …